What is the recommended dosage of MiraLAX (polyethylene glycol 3350) for pediatric patients with constipation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MiraLAX Dosing for Pediatric Constipation

For pediatric functional constipation, start with 0.4 g/kg/day of polyethylene glycol 3350 (MiraLAX) mixed in at least 4-8 ounces of liquid, adjusting the dose between 0.2-0.8 g/kg/day based on response. 1

Initial Dosing Strategy

  • Begin with 0.4 g/kg/day as the optimal starting dose for children with functional constipation, as this dose demonstrates the best balance of efficacy and tolerability 1
  • Lower doses of 0.2 g/kg/day are effective but may require upward titration 1
  • Higher doses of 0.8 g/kg/day increase the risk of abdominal pain and fecal incontinence without significantly improving outcomes 1
  • The typical maintenance dose averages 0.78-0.84 g/kg/day (range 0.26-1.42 g/kg/day) 2, 3

Age-Specific Considerations

  • For infants younger than 18 months, PEG 3350 is safe and effective at a mean maintenance dose of 0.78 g/kg/day, with similar safety profiles to older children 3
  • Limited data exists for infants under 6 months, though small case series show efficacy at similar weight-based dosing 3
  • The American Gastroenterological Association cautions against stimulant laxatives as first-line therapy in infants due to unknown long-term safety 4

Critical Administration Requirements

  • Mix the powder in at least 4-8 ounces of liquid—insufficient volume is the most common cause of treatment failure 5
  • Acceptable liquids include water, juice, coffee, or tea 5
  • Juices containing sorbitol (prune, pear, apple) provide synergistic osmotic effects and are particularly useful 5, 4
  • Ensure adequate daily fluid intake beyond just the mixing liquid, as PEG requires water to work osmotically 5, 6

Dose Titration Protocol

  • Adjust the dose every 3 days as needed to achieve 2 soft stools per day 2
  • Target stool frequency of ≥3 bowel movements per week with soft consistency 1
  • If no bowel movement occurs after 3-4 days, add a bisacodyl suppository (10mg) or glycerin suppository while continuing PEG 5, 6
  • For persistent constipation despite optimal PEG dosing, consider adding an oral stimulant laxative (senna or bisacodyl) to the regimen 5, 6

Expected Outcomes and Duration

  • Stool frequency typically increases from 2-3 per week to 15-17 per week during treatment 2
  • Stool consistency improves significantly at doses of 0.4 g/kg or higher 1
  • In children with encopresis, soiling events decrease from approximately 10 per week to 1-2 per week 2
  • Continue maintenance dosing once bowel movements normalize rather than stopping abruptly 5
  • Treatment response is durable over 6 months in adults, suggesting similar long-term efficacy in children 5

Safety Profile and Adverse Effects

  • PEG 3350 is well tolerated with minimal adverse effects 1, 2, 3
  • Transient diarrhea may occur but typically resolves with dose adjustment 3
  • Abdominal distension, flatulence, and nausea are generally mild 5
  • Higher doses (0.8 g/kg/day) increase the risk of abdominal pain and fecal incontinence 1

Pre-Treatment Assessment

  • Rule out bowel obstruction or paralytic ileus before initiating therapy 5
  • Check for fecal impaction, which may require manual disimpaction or enema before starting PEG 5
  • Avoid sodium phosphate preparations in young children due to risk of electrolyte abnormalities and mucosal injury 4
  • Use magnesium-based laxatives with caution in patients with renal concerns 4

Common Clinical Pitfalls to Avoid

  • Inadequate liquid volume (less than 4-8 ounces) significantly reduces efficacy 5, 6
  • Not confirming adequate daily fluid intake beyond the mixing liquid leads to treatment failure 5, 6
  • Assuming treatment failure without first optimizing dose and ensuring compliance 5, 6
  • Delaying rectal intervention beyond 3-4 days without a bowel movement increases fecal impaction risk 5, 6
  • Stopping therapy prematurely once symptoms improve rather than continuing maintenance dosing 5

Adjunctive Measures

  • Address underlying constipation with dietary modifications, including increased fluids and fiber if adequate fluid intake is ensured 5
  • Encourage regular toileting habits, especially after meals 5
  • For mild, recent-onset constipation, sorbitol-containing juices (2-4 oz daily) may be sufficient before escalating to PEG 4

References

Research

Polyethylene glycol for constipation in children younger than eighteen months old.

Journal of pediatric gastroenterology and nutrition, 2004

Guideline

Medication for Constipation in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pediatric Dosing of MiraLAX (Polyethylene Glycol 3350)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Neurogenic Bowel Constipation with Polyethylene Glycol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended dose of Glycolax (polyethylene glycol 3350) for a 3-year-old child with moderate constipation?
What is the recommended dosing of MiraLAX (polyethylene glycol 3350) for pediatric patients with constipation, considering age and weight?
What medications are recommended for treating constipation in pediatric patients?
What is the recommended duration of polyethylene glycol (PEG) treatment for an 8-year-old patient with constipation?
What is the recommended dosage and usage of Miralax (polyethylene glycol 3350) for treating constipation in pediatric patients?
What is the diagnosis and management for a patient with a 1-day history of right ear pain and muffled hearing, who has a history of ear infections, is hemodynamically stable, afebrile, with a swollen External Auditory Canal (EAC) and erythema, and a perforated Tympanic Membrane (TM) after ear lavage due to cerumen impaction?
What is the protocol for Hepamerz (Hepatitis B Immunoglobulin) infusion in a patient exposed to Hepatitis B?
What dietary recommendations are suitable for a patient with rheumatoid arthritis (RA) to manage symptoms and support overall health?
What is the best approach to rule out digital vascular injury in a digit?
What is the ideal time to schedule a repeat cesarean section (CS) for a patient who is at least 18-24 months post-previous CS and has no other medical complications?
What are the ventilator settings for patients with different respiratory diseases, including Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), pneumonia, and asthma?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.